The peptide problem: Hype is outrunning the evidence FDA Updates Safety Label for Capecitabine and 5 FU for Risks Associated With DPD Deficiency Oncology Nursing Society BPC 157: Experimental Peptide Creates Risk for Athletes FDA to weigh easing limits on unproven peptides FDA takes first step in possible reversal of ban on some peptides The Washington Post Does BPC 157 Cause Erectile Dysfunction? Evidence and Safe Treatments Bolt Pharmacy